跳至主要内容
临床试验/NCT05572723
NCT05572723已完成4 期

Comparison of the Effects of Remifentanil and Dexmedetomidine Administered Under General Anesthesia in Rhinoplasty

Baskent University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Mean arterial pressure

研究概览

简要总结

The investigators compared the effects of remifentanil and dexmedetomidine administered under general anesthesia on hemodynamics, postoperative pain, recovery, postoperative nausea, vomiting, shivering, patient's and surgeon's satisfaction in patients undergoing elective rhinoplasty. A single-center, prospective, blinded, randomized controlled trial. After the approval of the hospital ethics committee (KA22/12), fifty volunteers aged 18-65 years who underwent rhinoplasty under elective conditions accepted the study in the American Society of Anesthesiologists (ASA) I-III class. The patients were randomly divided into the remifentanil group (group R) and the dexmedetomidine group (group D). Group R (n=25) was initially to receive remifentanil 0.01-0.2 g/kg/min without intraoperative loading. Group D (n=25) dexmedetomidine, was initiated with a bolus of 1 mg/kg and received 0.2-0.7 g/kg per hour as an infusion during surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Other
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who will have rhinoplasty surgery American Society of Anesthesiologists (ASA) I- II class

排除标准

  • Patients with end-stage liver or kidney disease Uncontrolled hypertension Any type of atrioventricular block, pacemaker Heart failure Diabetes mellitus Chronic obstructive or interstitial lung disease, severe asthma Neurological or psychiatric disease, substance abuse Pregnant or lactating women

研究组 & 干预措施

Group Remifentanil

Active Comparator

Remifentanil group was initially to receive remifentanil (group R), 0.01-0.2 g/kg/min without intraoperative loading.

干预措施: Remifentanil 2 MG (Drug)

Group Dexmedetomidine

Active Comparator

Dexmedetomidine group, dexmedetomidine (group D) was initiated with a bolus of 1 mg/kg and received 0.2-0.7 g/kg per hour as an infusion during surgery.

干预措施: dexmedetomidine (Drug)

结局指标

主要结局

Mean arterial pressure

时间窗: During surgery

The investigators compare the stability of mean arterial pressure.

Postoperative pain

时间窗: Up to 30 minutes after the patient wakes up.

The investigators compare the effect of remifentanil and dexmedetomidine on postoperative pain. The patients pain level was assessed using the numeric pain scale (Between 0-10, 0 = no pain, 10 = worst pain).

Patient Recovery Time

时间窗: Postoperative 1. hours

The investigators compare the effect of remifentanil and dexmedetomidine on patient recovery time. The recovery time of the patient will be evaluated by calculating the time between extubated and discharged from the postoperative care unit.

次要结局

  • Postoperative nausea and vomiting scores(postoperative first 6 hours and 24 hours)
  • Patient satisfaction(Postoperative 6. hours)
  • Surgeon satisfaction(Postoperative 0. hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zeynep Ersoy

Assistant professor

Baskent University

研究点 (1)

Loading locations...

相似试验